Borgmann-Winter Karin E, Wang Hoau-Yan, Ray Rabindranath, Willis Brooke R, Moberg Paul J, Rawson Nancy E, Gur Raquel E, Turetsky Bruce I, Hahn Chang-Gyu
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA; Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA;
Department of Physiology, Pharmacology and Neuroscience, City University of New York Medical School, New York, NY;
Schizophr Bull. 2016 Mar;42(2):377-85. doi: 10.1093/schbul/sbv129. Epub 2015 Sep 15.
Increasing evidence suggests that olfactory dysfunction is an endophenotype of schizophrenia, and thus the olfactory system can be studied both in relation to this sensory dysfunction and also as a means of examining pathophysiologic mechanisms of schizophrenia. In this study, we examined human olfactory neuroepithelial (ON) biopsy tissues and their in vitro culture cells for ligand-induced guanine nucleotide-binding protein (G protein) activation and downstream signaling. We assessed the binding of a nonhydrolyzable GTP analogue [(35)S]GTPγS binding to specific G protein subtypes in response to odorants, dopamine, or serotonin in ON cell membranes from matched schizophrenia-control subjects. In response to odorant mixtures, we found decreased [(35)S]GTPγS binding to Gαs/olf in schizophrenia patients. These changes were not mediated by mRNA expression of key molecules of G protein coupling, including adenylate cyclase III (ACIII), protein kinase A (PKA), protein kinase Cγ (PKCγ), or Gαs or Gαolf in ON cells or ON biopsy tissues. In contrast, dopamine (DA)- and serotonin (5HT)-induced S(35)-GTPγS binding to Gαs/olf and Gαq/11 were significantly increased in schizophrenia cases, while these parameters were strikingly reduced by in vitro treatment with antipsychotics. Patients with schizophrenia exhibit increases in electrolfactogram (EOG) recordings, suggesting enhanced odorant-induced activation. Our results of decreased odorant-induced G protein activation may point further downstream for underlying mechanisms for increased EOG measures. Increased G protein activation in response to DA and 5HT may suggest increased postreceptor DA or 5HT signaling as an additional mechanism of dopaminergic or serotonergic dysregulation in schizophrenia.
越来越多的证据表明嗅觉功能障碍是精神分裂症的一种内表型,因此嗅觉系统既可以作为研究这种感觉功能障碍的对象,也可以作为研究精神分裂症病理生理机制的一种手段。在本研究中,我们检测了人类嗅神经上皮(ON)活检组织及其体外培养细胞中配体诱导的鸟嘌呤核苷酸结合蛋白(G蛋白)激活和下游信号传导。我们评估了来自匹配的精神分裂症对照受试者的ON细胞膜中,不可水解的GTP类似物[(35)S]GTPγS与特定G蛋白亚型的结合,该结合是对气味剂、多巴胺或血清素的反应。在对气味剂混合物的反应中,我们发现精神分裂症患者中[(35)S]GTPγS与Gαs/olf的结合减少。这些变化不是由G蛋白偶联关键分子的mRNA表达介导的,这些关键分子包括ON细胞或ON活检组织中的腺苷酸环化酶III(ACIII)、蛋白激酶A(PKA)、蛋白激酶Cγ(PKCγ)或Gαs或Gαolf。相比之下,多巴胺(DA)和血清素(5HT)诱导的S(35)-GTPγS与Gαs/olf和Gαq/11的结合在精神分裂症病例中显著增加,而这些参数在体外使用抗精神病药物治疗后显著降低。精神分裂症患者的嗅觉电图(EOG)记录增加,表明气味剂诱导的激活增强。我们关于气味剂诱导的G蛋白激活减少的结果可能指向EOG测量增加的潜在机制的更下游环节。对DA和5HT反应中G蛋白激活增加可能表明受体后DA或5HT信号增加,这是精神分裂症中多巴胺能或5-羟色胺能失调的另一种机制。